Company profile: BioPorto
1.1 - Company Overview
Company description
- Provider of in-vitro diagnostic products, offering a range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. Portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioPorto
DIAsource Diagnostics
HQ: Belgium
Website
- Description: Provider of clinical diagnostic products and IVD solutions, developing, manufacturing, and marketing RIA and ELISA assays (manual and automated) for endocrinology, autoimmunity, and infectious diseases; monoclonal antibodies for in-vitro diagnostic assays; DIASpot immunodot platform for auto-immune testing; free 25OH Vitamin D assays; and the DIA5000 rapid test reader.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DIAsource Diagnostics company profile →
CyVek
HQ: United States
Website
- Description: Provider of a platform technology for measuring analytes in biological samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CyVek company profile →
Elitech
HQ: France
Website
- Description: Provider of in vitro diagnostic equipment, reagents, and software for clinical and research laboratories, offering molecular diagnostics, clinical chemistry benchtop analyzers, microbiology solutions, and biomedical systems. Portfolio includes Selectra Mach5 and Selectra Pro & Mach5 systems with ready-to-use reagents, calibrators, controls, and consumables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elitech company profile →
Abaxis
HQ: United States
Website
- Description: Provider of point-of-care blood analyzers and diagnostics for physicians and veterinarians, including the Piccolo Xpress for real-time blood chemistry results from small samples; single-use reagent discs with up to 14 tests; a Data Manager for electronic records; an online Medical Reference Center; and technical service for installation and support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abaxis company profile →
Immunodiagnostic Systems
HQ: United Kingdom
Website
- Description: Provider of in-vitro diagnostic solutions for clinical and research laboratories, including the IDS-iSYS multi-discipline automated system, automated and manual immunoassays, endocrinology and autoimmunity assay portfolios, and therapeutic drug monitoring. Development focuses on bone and calcium metabolism, growth, hypertension, and chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunodiagnostic Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioPorto
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioPorto
2.2 - Growth funds investing in similar companies to BioPorto
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioPorto
4.2 - Public trading comparable groups for BioPorto
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →